Inflammatory mediators increase SUMOylation of retinoid X receptor α in a c-Jun N-terminal kinase-dependent manner in human hepatocellular carcinoma cells

Molecular Pharmacology

Volumn 84, Issue 2, 2013, Pages 218-226

  Aguirre, Rebecca Schneider ^a   Karpen, Saul J ^a,b,c  

^a Department of Molecular and Cellular Biology ^*  (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; CELL NUCLEUS RECEPTOR; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; RETINOID X RECEPTOR ALPHA; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING SITE; CANCER CELL; CANCER CELL CULTURE; CELL FRACTIONATION; GENE CONTROL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INFLAMMATION; LIVER CELL CARCINOMA; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REAL TIME POLYMERASE CHAIN REACTION; SUMOYLATION; TRANSIENT TRANSFECTION;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; HEPATOCYTES; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIGANDS; LIVER; LIVER NEOPLASMS; ORGANIC CHEMICALS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RETINOID X RECEPTOR ALPHA; SIGNAL TRANSDUCTION; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION; TRETINOIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84880611926     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.113.085555     Document Type: Article

References (54)

1. Adam-Stitah S, Penna L, Chambon P, and Rochette-Egly C (1999) Hyperphosphorylation of the retinoid X receptor alpha by activated c-Jun NH2-terminal kinases. J Biol Chem 274:18932-18941.
2. Ananthanarayanan M, Balasubramanian N, Makishima M, Mangelsdorf DJ, and Suchy FJ (2001) Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J Biol Chem 276:28857-28865.
3. Arito M, Horiba T, Hachimura S, Inoue J, and Sato R (2008) Growth factor-induced phosphorylation of sterol regulatory element-binding proteins inhibits sumoylation, thereby stimulating the expression of their target genes, low density lipoprotein uptake, and lipid synthesis. J Biol Chem 283:15224-15231.
4. Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, and Feingold KR (2000) The acute phase response is associated with retinoid X receptor repression in rodent liver. J Biol Chem 275:16390-16399.
5. Bohren KM, Nadkarni V, Song JH, Gabbay KH, and Owerbach D (2004) A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J Biol Chem 279:27233-27238.
6. Cherrington NJ, Slitt AL, Li N, and Klaassen CD (2004) Lipopolysaccharidemediated regulation of hepatic transporter mRNA levels in rats. Drug Metab Dispos 32:734-741.
7. Choi SJ, Chung SS, Rho EJ, Lee HW, Lee MH, Choi HS, Seol JH, Baek SH, Bang OS, and Chung CH (2006) Negative modulation of RXRalpha transcriptional activity by small ubiquitin-related modifier (SUMO) modification and its reversal by SUMO specific protease SUSP1. J Biol Chem 281:30669-30677.
8. Davidson-Moncada J, Papavasiliou FN, and Tam W (2010) MicroRNAs of the immune system: roles in inflammation and cancer. Ann N Y Acad Sci 1183:183-194.
9. Davies L, Karthikeyan N, Lynch JT, Sial EA, Gkourtsa A, Demonacos C, and Krstic-Demonacos M (2008) Cross talk of signaling pathways in the regulation of the glucocorticoid receptor function. Mol Endocrinol 22:1331-1344.
10. Germain P, Staels B, Dacquet C, Spedding M, and Laudet V (2006) Overview of nomenclature of nuclear receptors. Pharmacol Rev 58:685-704.
11. Ghisletti S, Huang W, Ogawa S, Pascual G, Lin ME, Willson TM, Rosenfeld MG, and Glass CK (2007) Parallel SUMOylation-dependent pathways mediate geneand signal-specific transrepression by LXRs and PPARgamma. Mol Cell 25:57-70.
12. Ghose R, Mulder J, von Furstenberg RJ, Thevananther S, Kuipers F, and Karpen SJ (2007) Rosiglitazone attenuates suppression of RXRalpha-dependent gene expression in inflamed liver. J Hepatol 46:115-123.
13. Ghose R, Zimmerman TL, Thevananther S, and Karpen SJ (2004) Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: A novel mechanism for reduced hepatic gene expression in inflammation. Nucl Recept 2:4.
14. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, and Roth ME et al. (2000) A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6:517-526.
15. Grün F and Blumberg B (2006) Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147(6, Suppl)S50-S55.
16. Guo B and Sharrocks AD (2009) Extracellular signal-regulated kinase mitogenactivated protein kinase signaling initiates a dynamic interplay between sumoylation and ubiquitination to regulate the activity of the transcriptional activator PEA3. Mol Cell Biol 29:3204-3218.
17. Hietakangas V, Anckar J, Blomster HA, Fujimoto M, Palvimo JJ, Nakai A, and Sistonen L (2006) PDSM, a motif for phosphorylation-dependent SUMO modification. Proc Natl Acad Sci USA 103:45-50.
18. Hu G, Xu C, and Staudinger JL (2010) Pregnane X receptor is SUMOylated to repress the inflammatory response. J Pharmacol Exp Ther 335:342-350.
19. Imai T (2003) Functional genetic dissection of nuclear receptor signalling in obesity, diabetes and liver regeneration using spatiotemporally controlled somatic mutagenesis in the mouse. Keio J Med 52:198-203.
20. Johnson ES (2004) Protein modification by SUMO. Annu Rev Biochem 73:355-382.
21. Kim MS, Sweeney TR, Shigenaga JK, Chui LG, Moser A, Grunfeld C, and Feingold KR (2007) Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells. Metabolism 56:267-279.
22. Kosters A and Karpen SJ (2008) Bile acid transporters in health and disease. Xenobiotica 38:1043-1071.
23. Kosters A and Karpen SJ (2010) The role of inflammation in cholestasis: clinical and basic aspects. Semin Liver Dis 30:186-194.
24. Kosters A, White DD, Sun H, Thevananther S, and Karpen SJ (2009) Redundant roles for cJun-N-terminal kinase 1 and 2 in interleukin-1beta-mediated reduction and modification of murine hepatic nuclear retinoid X receptor alpha. J Hepatol 51:898-908.
25. Kuenzli S, Tran C, and Saurat JH (2004) Retinoid receptors in inflammatory responses: a potential target for pharmacology. Curr Drug Targets Inflamm Allergy 3:355-360.
26. Le Vee M, Gripon P, Stieger B, and Fardel O (2008) Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta. Drug Metab Dispos 36:217-222.
27. Lefebvre P, Benomar Y, and Staels B (2010) Retinoid X receptors: common heterodimerization partners with distinct functions. Trends Endocrinol Metab 21: 676-683.
28. Leitao B, Jones MC, Fusi L, Higham J, Lee Y, Takano M, Goto T, Christian M, Lam EW, and Brosens JJ (2010) Silencing of the JNK pathway maintains progesterone receptor activity in decidualizing human endometrial stromal cells exposed to oxidative stress signals. FASEB J 24:1541-1551.
29. Leuenberger N, Pradervand S, and Wahli W (2009) Sumoylated PPARalpha mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice. J Clin Invest 119:3138-3148.
30. Macoritto M, Nguyen-Yamamoto L, Huang DC, Samuel S, Yang XF, Wang TT, White JH, and Kremer R (2008) Phosphorylation of the human retinoid X receptor alpha at serine 260 impairs coactivator(s) recruitment and induces hormone resistance to multiple ligands. J Biol Chem 283:4943-4956.
31. Mann KK, Padovani AM, Guo Q, Colosimo AL, Lee HY, Kurie JM, and Miller WH, Jr (2005) Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK-mediated RXRalpha phosphorylation. J Clin Invest 115:2924-2933.
32. Mark M, Ghyselinck NB, and Chambon P (2009) Function of retinoic acid receptors during embryonic development. Nucl Recept Signal 7:e002.
33. Mulder J, Karpen SJ, Tietge UJ, and Kuipers F (2009) Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis. Front Biosci 14:2599-2630.
34. Núñez V, Alameda D, Rico D, Mota R, Gonzalo P, Cedenilla M, Fischer T, Boscá L, Glass CK, and Arroyo AG et al. (2010) Retinoid X receptor alpha controls innate inflammatory responses through the up-regulation of chemokine expression. Proc Natl Acad Sci USA 107:10626-10631.
35. Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, Rose DW, Willson TM, Rosenfeld MG, and Glass CK (2005) A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437: 759-763.
36. Piton A, Rauch C, Langouet S, Guillouzo A, and Morel F (2010) Involvement of pregnane X receptor in the regulation of CYP2B6 gene expression by oltipraz in human hepatocytes. Toxicol In Vitro 24:452-459.
37. Plass JR, Mol O, Heegsma J, Geuken M, Faber KN, Jansen PL, and Müller M (2002) Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump. Hepatology 35:589-596.
38. Ruminy P, Gangneux C, Claeyssens S, Scotte M, Daveau M, and Salier JP (2001) Gene transcription in hepatocytes during the acute phase of a systemic inflammation: from transcription factors to target genes. Inflamm Res 50:383-390.
39. Saez-Rodriguez J, Alexopoulos LG, Zhang M, Morris MK, Lauffenburger DA, and Sorger PK (2011) Comparing signaling networks between normal and transformed hepatocytes using discrete logical models. Cancer Res 71:5400-5411.
40. Shulman AI, Larson C, Mangelsdorf DJ, and Ranganathan R (2004) Structural determinants of allosteric ligand activation in RXR heterodimers. Cell 116: 417-429.
41. Shulman AI and Mangelsdorf DJ (2005) Retinoid x receptor heterodimers in the metabolic syndrome. N Engl J Med 353:604-615.
42. Solomon C, White JH, and Kremer R (1999) Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D3-dependent signal transduction by phosphorylating human retinoid X receptor alpha. J Clin Invest 103:1729-1735.
43. Staudinger JL, Xu C, Biswas A, and Mani S (2011) Post-translational modification of pregnane x receptor. Pharmacol Res 64:4-10.
44. Tompkins LM and Wallace AD (2007) Mechanisms of cytochrome P450 induction. J Biochem Mol Toxicol 21:176-181.
45. Treuter E and Venteclef N (2011) Transcriptional control of metabolic and inflammatory pathways by nuclear receptor SUMOylation. Biochim Biophys Acta 1812:909-918.
46. Utsubo-Kuniyoshi R, Terui Y, Mishima Y, Rokudai A, Mishima Y, Sugimura N, Kojima K, Sonoda Y, Kasahara T, and Hatake K (2007) MEK-ERK is involved in SUMO-1 foci formation on apoptosis. Cancer Sci 98:569-576.
47. Venteclef N, Jakobsson T, Ehrlund A, Damdimopoulos A, Mikkonen L, Ellis E, Nilsson LM, Parini P, Jänne OA, and Gustafsson JA et al. (2010) GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response. Genes Dev 24:381-395.
48. Wagner M, Zollner G, and Trauner M (2010) Nuclear receptor regulation of the adaptive response of bile acid transporters in cholestasis. Semin Liver Dis 30: 160-177.
49. Wang H, Faucette S, Moore R, Sueyoshi T, Negishi M, and LeCluyse E (2004) Human constitutive androstane receptor mediates induction of CYP2B6 gene expression by phenytoin. J Biol Chem 279:29295-29301.
50. Wang R, Sheps JA, and Ling V (2011) ABC transporters, bile acids, and inflammatory stress in liver cancer. Curr Pharm Biotechnol 12:636-646.
51. Wauters J, Mesotten D, Van Zwam K, van Pelt J, Thiessen S, Dieudonné AS, Vander Borght S, Van den Berghe G, and Wilmer A (2010) The impact of resuscitated fecal peritonitis on the expression of the hepatic bile salt transporters in a porcine model. Shock 34:508-516.
52. Zimmerman TL, Ghose R, Thevananther S, and Karpen SJ (2003) Il-1 beta mediated modification and nucleo-cytoplasmic translocation of RXR alpha involves JNK. Hepatology 38:391A-391A.
53. Zimmerman TL, Ghose R, Thevananther S, and Karpen SJ (2004) IL-1 beta induced RXR alpha nuclear export requires JNK activated cell signaling and involves serine. Hepatology 40:213A-213A.
54. Zimmerman TL, Thevananther S, Ghose R, Burns AR, and Karpen SJ (2006) Nuclear export of retinoid X receptor alpha in response to interleukin-1beta- mediated cell signaling: roles for JNK and SER260. J Biol Chem 281:15434-15440. Digestive and Kidney Diseases